- Home
- IMUX vs VIOT Comparison
IMUX vs VIOT Comparison
Compare IMUX & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- VIOT
- Stock Information
- Founded
- IMUX 2016
- VIOT 2014
- Country
- IMUX United States
- VIOT China
- Employees
- IMUX N/A
- VIOT N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- VIOT Consumer Electronics/Appliances
- Sector
- IMUX Health Care
- VIOT Consumer Discretionary
- Exchange
- IMUX Nasdaq
- VIOT Nasdaq
- Market Cap
- IMUX 86.3M
- VIOT 102.5M
- IPO Year
- IMUX N/A
- VIOT 2018
- Fundamental
- Price
- IMUX $1.27
- VIOT $1.61
- Analyst Decision
- IMUX Strong Buy
- VIOT
- Analyst Count
- IMUX 6
- VIOT 0
- Target Price
- IMUX $12.67
- VIOT N/A
- AVG Volume (30 Days)
- IMUX 795.3K
- VIOT 95.6K
- Earning Date
- IMUX 03-04-2025
- VIOT 03-24-2025
- Dividend Yield
- IMUX N/A
- VIOT N/A
- EPS Growth
- IMUX N/A
- VIOT N/A
- EPS
- IMUX N/A
- VIOT N/A
- Revenue
- IMUX N/A
- VIOT $306,754,324.00
- Revenue This Year
- IMUX N/A
- VIOT N/A
- Revenue Next Year
- IMUX N/A
- VIOT N/A
- P/E Ratio
- IMUX N/A
- VIOT N/A
- Revenue Growth
- IMUX N/A
- VIOT N/A
- 52 Week Low
- IMUX $0.92
- VIOT $0.50
- 52 Week High
- IMUX $2.11
- VIOT $1.94
- Technical
- Relative Strength Index (RSI)
- IMUX 72.48
- VIOT 58.61
- Support Level
- IMUX $0.92
- VIOT $1.57
- Resistance Level
- IMUX $1.15
- VIOT $1.78
- Average True Range (ATR)
- IMUX 0.07
- VIOT 0.12
- MACD
- IMUX 0.03
- VIOT 0.03
- Stochastic Oscillator
- IMUX 74.47
- VIOT 67.31
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. It has developed an IoT Home platform, consisting of an ecosystem of IoT Home portfolio, and home water solutions, together with a suite of complementary consumable products and small appliances and others. Its product offerings include Smart kitchen products like refrigerators, oven steamers, dishwashers, and gas stoves, Other smart products such as air conditioning systems, washing machines, water heaters, smart water kettles, interactive smart screens and other smart devices, and Home water solutions include self-branded and Xiaomi-branded smart water purifiers.